Antion Biosciences SA is a cell and gene engineering biotechnology company based in Geneva (Switzerland), developing allogeneic immune cell therapies for the treatment of diseases with significant unmet medical needs. Antions proprietary gene silencing and miCAR technologies allow for a modular and tunable approach to multiplex engineering of therapeutic cells. By developing off-the-shelf therapies, our goal is to optimize treatment efficacy and safety while ensuring equitable access to these life-transforming therapies for all patients.